Witzke O - Search Results

1

Impact of low-level BK polyomavirus viremia on intermediate-term renal allograft function.

Korth J, Widera M, Dolff S, Guberina H, Bienholz A, Brinkhoff A, Anastasiou OE, Kribben A, Dittmer U, Verheyen J, Wilde B, Witzke O. Korth J, et al. Among authors: witzke o. Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12817. Epub 2018 Jan 16. Transpl Infect Dis. 2018. PMID: 29156086

2

Metabolic factors have a major impact on kidney allograft survival.

Hamar P, Müller V, Kohnle M, Witzke O, Albrecht KH, Philipp T, Heemann U. Hamar P, et al. Among authors: witzke o. Transplantation. 1997 Oct 27;64(8):1135-9. doi: 10.1097/00007890-199710270-00009. Transplantation. 1997. PMID: 9355829

3

Impact of febrile infections on the long-term function of kidney allografts.

Witzke O, Schmidt C, Kohnle M, Lütkes P, Philipp T, Heemann U. Witzke O, et al. J Urol. 2001 Dec;166(6):2048-52. J Urol. 2001. PMID: 11696704

4

Interleukin-2 given to asymptomatic HIV-infected individuals leads to an exaggerated response of the pituitary gland to the action of CRH.

Witzke O, Winterhagen T, Kribben A, Philipp T, Mann K, Reinhardt W. Witzke O, et al. Clin Endocrinol (Oxf). 2003 Jul;59(1):104-9. doi: 10.1046/j.1365-2265.2003.01803.x. Clin Endocrinol (Oxf). 2003. PMID: 12807511

5

A patient without monocytes who had pulmonary renal syndrome.

Witzke O, Patschan D, Dürig J, Lindemann M, Wenzel RR, Philipp T, Grosse-Wilde H, Kribben A. Witzke O, et al. Am J Kidney Dis. 2004 Sep;44(3):556-8. Am J Kidney Dis. 2004. PMID: 15332229

6

Serum C3 complement concentrations correlate with liver function in patients with liver cirrhosis.

Baumann M, Witzke O, Canbay A, Patschan S, Treichel U, Gerken G, Philipp T, Kribben A. Baumann M, et al. Among authors: witzke o. Hepatogastroenterology. 2004 Sep-Oct;51(59):1451-3. Hepatogastroenterology. 2004. PMID: 15362774

7

Which patients benefit from hemodialysis therapy in hepatorenal syndrome?

Witzke O, Baumann M, Patschan D, Patschan S, Mitchell A, Treichel U, Gerken G, Philipp T, Kribben A. Witzke O, et al. J Gastroenterol Hepatol. 2004 Dec;19(12):1369-73. doi: 10.1111/j.1440-1746.2004.03471.x. J Gastroenterol Hepatol. 2004. PMID: 15610310

8

Rosiglitazone is a safe and effective treatment option of new-onset diabetes mellitus after renal transplantation.

Pietruck F, Kribben A, Van TN, Patschan D, Herget-Rosenthal S, Janssen O, Mann K, Philipp T, Witzke O. Pietruck F, et al. Among authors: witzke o. Transpl Int. 2005 Apr;18(4):483-6. doi: 10.1111/j.1432-2277.2004.00076.x. Transpl Int. 2005. PMID: 15773972 Free article. Clinical Trial.

9

Ezetimibe for the treatment of uncontrolled hypercholesterolemia in patients with high-dose statin therapy after renal transplantation.

Kohnle M, Pietruck F, Kribben A, Philipp T, Heemann U, Witzke O. Kohnle M, et al. Among authors: witzke o. Am J Transplant. 2006 Jan;6(1):205-8. doi: 10.1111/j.1600-6143.2005.01132.x. Am J Transplant. 2006. PMID: 16433776 Free article. Clinical Trial.

10

OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.

Patschan D, Kribben A, Pietruck F, Lutz J, Binek M, Philipp T, Heemann U, Witzke O. Patschan D, et al. Among authors: witzke o. Nephron Clin Pract. 2006;103(3):c94-9. doi: 10.1159/000092017. Epub 2006 Mar 13. Nephron Clin Pract. 2006. PMID: 16534238 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters